These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
319 related items for PubMed ID: 34999964
1. Neurological sedative indicators during general anesthesia with remimazolam. Shirozu K, Nobukuni K, Tsumura S, Imura K, Nakashima K, Takamori S, Higashi M, Yamaura K. J Anesth; 2022 Apr; 36(2):194-200. PubMed ID: 34999964 [Abstract] [Full Text] [Related]
2. Comparative Analysis of the Performance of Electroencephalogram Parameters for Monitoring the Depth of Sedation During Remimazolam Target-Controlled Infusion. Bae MI, Bae J, Song Y, Kim M, Han DW. Anesth Analg; 2024 Jun 01; 138(6):1295-1303. PubMed ID: 38051672 [Abstract] [Full Text] [Related]
3. Comparison of bispectral index and patient state index as measures of sedation depth during surgeries using remimazolam tosilate. Zhao TY, Chen D, Xu ZX, Wang HL, Sun H. BMC Anesthesiol; 2023 Jun 15; 23(1):208. PubMed ID: 37322424 [Abstract] [Full Text] [Related]
4. Comparison of the bispectral indices of patients receiving remimazolam and propofol for general anesthesia: a randomized crossover trial. Yang C, Jiao J, Nie Y, Shao W, Zhang H, Huang S. Anaesth Crit Care Pain Med; 2024 Jun 15; 43(3):101377. PubMed ID: 38494158 [Abstract] [Full Text] [Related]
5. Performance of the SEDLine Monitor: Age Dependency and Time Delay. Obert DP, Schneider F, Schneider G, von Dincklage F, Sepulveda P, García PS, Kratzer S, Kreuzer M. Anesth Analg; 2023 Oct 01; 137(4):887-895. PubMed ID: 36727845 [Abstract] [Full Text] [Related]
6. Population pharmacokinetic/pharmacodynamic modeling for remimazolam in the induction and maintenance of general anesthesia in healthy subjects and in surgical subjects. Zhou J, Leonowens C, Ivaturi VD, Lohmer LL, Curd L, Ossig J, Schippers F, Petersen KU, Stoehr T, Schmith V. J Clin Anesth; 2020 Nov 01; 66():109899. PubMed ID: 32585566 [Abstract] [Full Text] [Related]
7. Comparative analysis of the effect of electromyogram to bispectral index and 95% spectral edge frequency under remimazolam and propofol anesthesia: a prospective, randomized, controlled clinical trial. Xin Y, Ma L, Xie T, Liang Y, Ma M, Chu T, Liu C, Xu A. Front Med (Lausanne); 2023 Nov 01; 10():1128030. PubMed ID: 37608826 [Abstract] [Full Text] [Related]
8. Quality of Recovery After General Anesthesia with Remimazolam in Patients' Undergoing Urologic Surgery: A Randomized Controlled Trial Comparing Remimazolam with Propofol. Mao Y, Guo J, Yuan J, Zhao E, Yang J. Drug Des Devel Ther; 2022 Nov 01; 16():1199-1209. PubMed ID: 35509490 [Abstract] [Full Text] [Related]
9. Total intravenous anesthesia induced and maintained by a combination of remimazolam and remifentanil without a neuromuscular blocking agent: a prospective, observational pilot study. Park I, Cho M, Nam SW, Hwang JW, Do SH, Na HS. BMC Anesthesiol; 2022 Jul 26; 22(1):237. PubMed ID: 35883039 [Abstract] [Full Text] [Related]
10. Simultaneous comparison of depth of sedation performance between SedLine and BIS during general anesthesia using custom passive interface hardware: study protocol for a prospective, non-blinded, non-randomized trial. Jones JH, Nittur VR, Fleming N, Applegate RL. BMC Anesthesiol; 2021 Apr 06; 21(1):105. PubMed ID: 33823811 [Abstract] [Full Text] [Related]
11. Safety and effcacy of remimazolam tosilate for sedation during combined spinal-epidural anesthesia for orthopedic procedures: a randomized controlled trial. Chen Y, Cai Y, Yu G, Zhang X, Hu T, Xue R. BMC Anesthesiol; 2024 Feb 26; 24(1):75. PubMed ID: 38408901 [Abstract] [Full Text] [Related]
12. Update on the SedLine® algorithm for calculating the Patient State Index of older individuals during general anesthesia: a randomized controlled trial. Obara S, Oishi R, Nakano Y, Noji Y, Ebana H, Isosu T, Kurosawa S, Murakawa M. Minerva Anestesiol; 2021 Jul 26; 87(7):774-785. PubMed ID: 33938673 [Abstract] [Full Text] [Related]
13. Electroencephalographic bispectral index correlates with intraoperative recall and depth of propofol-induced sedation. Liu J, Singh H, White PF. Anesth Analg; 1997 Jan 26; 84(1):185-9. PubMed ID: 8989022 [Abstract] [Full Text] [Related]
14. The Median Effective Dose and Bispectral Index of Remimazolam Tosilate for Anesthesia Induction in Elderly Patients: An Up-and-Down Sequential Allocation Trial. Liu M, Sun Y, Zhou L, Feng K, Wang T, Feng X. Clin Interv Aging; 2022 Jan 26; 17():837-843. PubMed ID: 35620021 [Abstract] [Full Text] [Related]
15. Safety and efficacy of remimazolam in induction and maintenance of general anesthesia in high-risk surgical patients (ASA Class III): results of a multicenter, randomized, double-blind, parallel-group comparative trial. Doi M, Hirata N, Suzuki T, Morisaki H, Morimatsu H, Sakamoto A. J Anesth; 2020 Aug 26; 34(4):491-501. PubMed ID: 32303884 [Abstract] [Full Text] [Related]
16. Remimazolam Tosylate Combined with Low-Dose Propofol Improves Sedation and Safety in Hysteroscopy. Zhang F, Chang H, Qing W, Yu R, Liao Q, Tong J. Drug Des Devel Ther; 2022 Aug 26; 16():4101-4108. PubMed ID: 36471692 [Abstract] [Full Text] [Related]
17. Frequency and characteristics of patients with bispectral index values of 60 or higher during the induction and maintenance of general anesthesia with remimazolam. Choi BM, Lee JS, Kim KM, Bang JY, Lee EK, Noh GJ. Sci Rep; 2023 Jun 20; 13(1):9992. PubMed ID: 37340043 [Abstract] [Full Text] [Related]
18. Target-controlled infusion of remimazolam effect-site concentration for total intravenous anesthesia in patients undergoing minimal invasive surgeries. Chon JY, Seo KH, Lee J, Lee S. Front Med (Lausanne); 2024 Jun 20; 11():1364357. PubMed ID: 38695029 [Abstract] [Full Text] [Related]
19. Efficacy and safety of remimazolam versus propofol for general anesthesia: a multicenter, single-blind, randomized, parallel-group, phase IIb/III trial. Doi M, Morita K, Takeda J, Sakamoto A, Yamakage M, Suzuki T. J Anesth; 2020 Aug 20; 34(4):543-553. PubMed ID: 32417976 [Abstract] [Full Text] [Related]
20. Target-controlled Infusion of Remimazolam in Healthy Volunteers Shows Some Acute Tolerance. Vellinga R, Koomen JV, Eleveld DJ, Stöhr T, Pesic M, Struys MMRF, Colin PJ. Anesthesiology; 2024 Feb 01; 140(2):207-219. PubMed ID: 37889844 [Abstract] [Full Text] [Related] Page: [Next] [New Search]